Impact of COVID19 Outbreak in Cardiac Acute Care
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris
About this trial
This registry will evaluate the impact of the COVID19 outbreak on Cardiac patients admitted in the Intensive Care Unit of the Pitie-Salpetriere Hospital in Paris, France
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18 years and older
Admitted in the Cardiac Intensive Care Unit from March 20th 2020
Patient informed and having expressed his non-opposition to participate in the research
Disqualifiers
Minor patient
Patient who expressed opposition to participation in the study
Trial population
All patients treated in the CCU at Cardiology Institute of the Pitié-Salpêtrière Hospital, from Friday, March 20, 2020
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
Data collection
Other interventionDiagnostic and prognostic evaluation of cardiac patients hospitalized in CCU during the COVID-19 outbreak; patient's immune status regarding the presence of SARS-CoV-2 specific antibodies
Treatment groups
500 Participants
are divided into 2 treatment groupsGroup A: COVID19- Population1 intervention
Group B: COVID19+ Population1 intervention
Trial outcomes
Primary outcomes
1
Incidence of recurrent Major Cardiovascular Events (MACE) and urgent rehospitalization
Time frame
From admission to one year follow upSponsors and contacts
Click on the lead sponsor to view all of their trials.
Assistance Publique - Hôpitaux de Paris
Lead sponsor
Action, France
Collaborator
Source ClinicalTrials.gov